IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ROMEO, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.268
NA - Nord America 5.638
AS - Asia 5.456
SA - Sud America 444
AF - Africa 149
OC - Oceania 37
Continente sconosciuto - Info sul continente non disponibili 6
Totale 17.998
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.464
GB - Regno Unito 2.045
CN - Cina 1.726
SG - Singapore 1.527
IT - Italia 1.142
DE - Germania 813
SE - Svezia 539
VN - Vietnam 481
HK - Hong Kong 464
RU - Federazione Russa 434
IN - India 305
BR - Brasile 300
FR - Francia 264
TR - Turchia 257
NL - Olanda 203
KR - Corea 190
UA - Ucraina 189
IE - Irlanda 144
FI - Finlandia 140
JP - Giappone 137
CA - Canada 106
BD - Bangladesh 101
DK - Danimarca 98
EU - Europa 79
ID - Indonesia 68
CI - Costa d'Avorio 63
CO - Colombia 59
BE - Belgio 41
PL - Polonia 39
ES - Italia 29
MX - Messico 29
GR - Grecia 28
AR - Argentina 27
IR - Iran 27
PH - Filippine 27
ZA - Sudafrica 27
AT - Austria 26
AU - Australia 22
IQ - Iraq 19
CH - Svizzera 18
PK - Pakistan 18
EC - Ecuador 17
NZ - Nuova Zelanda 15
CL - Cile 14
SA - Arabia Saudita 13
UZ - Uzbekistan 13
EG - Egitto 12
PT - Portogallo 12
VE - Venezuela 12
CZ - Repubblica Ceca 11
MY - Malesia 11
LB - Libano 9
MA - Marocco 9
RO - Romania 9
SI - Slovenia 8
IL - Israele 7
PE - Perù 7
TH - Thailandia 7
TW - Taiwan 7
CR - Costa Rica 6
KE - Kenya 6
NG - Nigeria 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
AL - Albania 5
AZ - Azerbaigian 5
BY - Bielorussia 5
JM - Giamaica 5
NP - Nepal 5
SC - Seychelles 5
TN - Tunisia 5
AO - Angola 4
CU - Cuba 4
GE - Georgia 4
JO - Giordania 4
LV - Lettonia 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
HU - Ungheria 3
KH - Cambogia 3
KZ - Kazakistan 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
NE - Niger 2
NO - Norvegia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TJ - Tagikistan 2
UY - Uruguay 2
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
Totale 18.049
Salva come PNG Salva come JPEG
Città #
Southend 1.847
Singapore 844
Ashburn 568
Milan 517
Chandler 421
Hong Kong 420
Beijing 351
San Jose 276
Seattle 274
Ann Arbor 266
Princeton 195
Dearborn 192
Frankfurt am Main 187
Wilmington 179
Council Bluffs 166
Santa Clara 166
Dallas 161
Fairfield 145
Los Angeles 143
Dublin 140
Jacksonville 135
Ho Chi Minh City 133
Hanoi 128
Munich 127
Woodbridge 125
Mountain View 115
Nanjing 115
Bengaluru 99
Hefei 95
Istanbul 94
Lauterbourg 88
Redmond 88
New York 84
Houston 79
Boardman 71
Jinan 71
Guangzhou 67
Abidjan 63
Des Moines 63
Phoenix 63
Shanghai 62
Shenyang 61
Grafing 60
Sakarya 60
Hanover 58
Serra 57
Moscow 56
Somerville 56
Cambridge 55
Toronto 55
Buffalo 54
Bogotá 50
Andover 48
Redwood City 48
Changsha 43
Tokyo 43
Helsinki 41
Seoul 41
Pisa 39
Brussels 38
Rome 38
Jakarta 35
Kent 35
Nanchang 35
Tianjin 35
Medford 33
Roxbury 33
Hangzhou 32
Berlin 29
The Dalles 29
Athens 28
Torino 28
Warsaw 28
Ningbo 26
Eitensheim 24
Columbus 23
Jiaxing 23
Da Nang 22
Hebei 22
Atlanta 21
Cangzhou 21
Zhengzhou 20
Fremont 19
Monza 19
São Paulo 19
Taizhou 19
Fuzhou 18
Haikou 18
Madison 18
Haiphong 17
Montreal 17
Mumbai 17
Düsseldorf 16
San Diego 16
Hamburg 15
Lanzhou 15
Piscataway 15
Turku 15
Wuhan 15
Bühl 14
Totale 11.308
Salva come PNG Salva come JPEG
Nome #
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 412
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor 394
How selection was made for a new antimalarial drug candidate : from AM1 to MG3, two novel series of 4-aminoquinoline derivatives 363
Selective and active targeting of neuropeptide Y receptors in experimental oncology: use of gold nanocages conjugated to short peptides 356
High antiplasmodial activity of novel plasmepsins I and II inhibitors 321
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline : A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial 308
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor 300
Old and new targets for innovative antimalarial compounds : the different strategies of the Italian Malaria Network 295
Antiplasmodial activity of Punica granatum L. fruit rind 285
Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region 281
4-Aminoquinoline-statine double drugs 263
Discovery and pharmacophore mapping of a new low nanomolar inhibitor of P. falciparum growth 261
Novel biotinylated bile acid amphiphiles: micellar aggregates formation and interaction with hepatocytes 260
High resolution mass spectrometry based approach to investigate RAGE-ligand interactions 256
Discovery of oxybisbenzoylamides as a new class of antimalarial agents 246
POMEGRANATE ELLAGITANNINS ANTAGONIZE IN VITRO THE INFLAMMATORY RESPONSE INVOLVED IN MALARIA 243
PLASMEPSIN II INHIBITION AND ANTIPLASMODIAL ACTIVITY OF PRIMAQUINE-STATINE “DOUBLE-DRUGS” 242
A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate 242
Synthesis of gallocatechin-3-gallate analogues 240
In vitro characterization, structural optimization and in silico pharmacophore modeling of a new antiplasmodial chemotype 239
Antiplasmodial activities of 4-aminoquinoline–statine compounds 235
Ellagitannins of the fruit rind of pomegranate (Punica granatutm) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria 231
A new high resolution mass spectrometry application for the comprehensive analysis of the ligand-binding properties of rage 228
Antiparasitic activities and toxicities of individual enantiomers of 7-chloro-N-[[(9a)-octahydro-2H-quinolizin-1-yl]methyl]-4-quinolinamine 226
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate 224
Gold nanocages for imaging and therapy of prostate cancer cells 224
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS 218
Antiparasitic activity and ADME-tox profile of new 4-aminoquinoline derivatives 209
Antiplasmodial activity of Punica granatum L. fruit rind 209
Novel inhibitors of Plasmepsins, a family of haemoglobin proteases of P. Falciparum 207
Listening to nature's hints : exploiting a natural product scaffold to simplify a complex chemical structure 205
Design, synthesis and docking studies of hydroxyethylamine and hydroxyethyl-sulfide bace-1 inhibitors 204
Parallel synthesis and antileishmanial activity of ether-linked phospholipids 204
Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinolines 203
[4-(2H-1,2,3-benzotriazol-2-yl)phenoxy]alkanoic acids as agonists of peroxisome proliferator-activated receptors (PPARs) 203
Perfluorinated probes for non-covalent protein recognition and isolation 201
Nitric oxide releasing hyaluronic esters 200
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment 198
In vitro and in vivo evaluation and early transitioning studies of novel quinolizidinyl- and quinolizidinylalkyl- derivatives of 4-aminoquinoline with potent antimalarial activity 197
Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities 196
“Blind” targeting in action : from phage display to breast cancer cell targeting with peptide-gold nanoconjugates 196
Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs' 195
A chemical proteomic approach in antimalarial drugs discovery 195
Structural optimization, in vitro characterization and in silico pharmacophore modeling of a new antiplasmodial chemotype 195
From DC18 to MR07: A Metabolically Stable 4,4′‐Oxybisbenzoyl Amide as a Low‐Nanomolar Growth Inhibitor of P. falciparum 193
Design, synthesis and docking studies of hydroxyethylamine and hydroxyethylsulfide BACE-1 inhibitors 191
Design and synthesis of protein–protein interaction mimics as plasmodium falciparum cysteine protease, falcipain-2 inhibitors 187
Chemical proteomics approach for target identification of a new antimalarials 187
SYNTHESIS OF ANALOGUES OF GALLOCATECHIN-3-GALLATE AS INHIBITORS OF METALLOPROTEINASE-9 ACTIVITY AND GENE EXPRESSION 186
Production of active recombinant PfPM1 and PbPM4 and inhibition analysis with a series of statine-based compounds 186
Ability of quinolizidinyl- and quinolizidinylalkyl-derivatives of 4-aminoquinoline to overcome chloroquine resistance 186
Targeting the plasmepsin 4 orthologs of Plasmodium sp with "Double Drug" inhibitors 184
Atovaquone-statine "Double-Drugs" with high antiplasmodial activity 183
Antiparasitic activity and ADME-Tox profile of new 4-aminoquinoline derivatives 183
INHIBITION OF BACE-1 BY HYDROXYETHYLAMINE AND HYDROXYETHYLSULFIDE ISOSTERIC REPLACEMENTS 182
Amino acid derived epoxide ring opening tinder microwave irradiation 182
DESIGN AND SYNTHESIS OF PROTEIN-PROTEIN INTERACTION MIMICS AS INHIBITORS OF PLASMODIUM FALCIPARUM CYSTEINE PROTEASE FALCIPAIN-2 181
Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl)aminoquinoline 181
Targeting the PM4 orthologs of Plasmodium sp 180
Solid phase synthesis of rage ligands 178
Identification and screeening of natural and synthetic products with significant antimalarial activity in vitro 176
Inhibition of BACE-1 by hydroxyethylsulfide, hydroxyethylamine and hydroxyethylurea isosteric replacements 175
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 175
A chemical proteomic approach in antimarial drugs discovery 174
Synthesis and antimycobacterial activity of (+)-usnic acid conjugates 174
Novel amodiaquine congeners as potent antimalarial agents 172
Alcohols immobilization onto 2-chlorotritylchloridenext term resin under microwave irradiation 171
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 168
Scale-up synthesis of MG3, a pyrrolizidinyl 4-aminoquinoline derivative, as novel antimalarial drug candidate 168
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate 167
Synthesis of a potent antimalarial agent through natural products conjugation 163
Nitric oxide donating carnosine compuunds 156
Inhibition of plasmepsin II and IV and antiplasmodial activity of primaquine-statine double drugs 152
Insights on the mechanism of action of novel quinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity 151
STUDIES FOR A DIASTEREOSELECTIVE SYNTHESIS OF THE TETRACYCLIC DITERPENIC DIOL STEMARIN - AN IMPROVED PROCEDURE FOR THE SYNTHESIS OF 8(9)-PODOCARPEN-14-ONES - THE TOTAL SYNTHESIS OF 18-BENZYLOXY-8(9)-PODOCARPEN-14-ONE AND RELATED STUDIES 148
Inhibition of Plasmepsins II and IV and Antiplasmodial Activity of Primaquine–Statine Double Drugs 145
STUDIES FOR A DIASTEREOSELECTIVE SYNTHESIS OF THE TETRACYCLIC DITERPENIC DIOL STEMARIN - A MODEL STUDY FOR A NEW PREPARATION OF THE KEY INTERMEDIATE AND THE SYNTHESIS OF (+)-18-DEOXYSTEMARIN 145
Design and synthesis of protein-protein interaction mimics as inhibitors of plasmodium cysteine protease falcipain-2 143
Direct interaction of natural and synthetic catechins with Signal Transducer Activator of Transcription-1 affects both its phosphorylation and activity 142
Identification of a new class of potent bace-1 inhibitors through scaffold hopping 142
Bovine hemoglobin cross-linked through the beta chains - Functional and structural aspects 141
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS. 139
The antimalarial activity of primaquine-statine "double drugs" correlates with the inhibition of plasmepsin II activity 139
Potente attività antimalarica di chinolizidinilalchil-derivati delle 4ammino-chinoline 138
Nitric oxide donating carnosine compuunds 137
A chemical proteomic approach in antimalarial drugs discovery 136
Synthetic peptides derived from the C-terminal 6kDa region of Plasmodium falciparum SERA5 inhibit the enzyme activity and malaria parasite development 134
Relationships between conformational behaviour and binding affinity towards beta1 and beta2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents 131
Novel quinolizidinyl and quinolizidinyl-alkyl derivatives of 4-aminoquinolines with potent antimalarial activity 124
Plasmepsin V, a new promising target for antimalarial drug discovery 122
Preclinical characterization of MG3, a new 4-aminoquinoline derivative with potent antimalarial activity 119
UNPRECEDENTED OUTCOME OF THE ALLENE PHOTOADDITION TO A FUSED ALPHA,BETA-UNSATURATED KETONE 116
Neuropeptide Y receptors 1 and 2 as molecular targets in prostate and breast cancer therapy 112
DIASTEREOSELECTIVE EPOXIDATION OF DIPEPTIDE OLEFINS 106
STEREOSELECTIVE SYNTHESIS OF PROTECTED AMINO ALKYL EPOXIDES 102
null 56
Totale 18.919
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.805
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.805
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021384 0 0 0 0 0 0 0 0 0 0 297 87
2021/20221.351 198 111 39 101 71 62 155 57 125 89 94 249
2022/20231.531 210 155 136 147 164 280 25 137 168 16 47 46
2023/20241.198 42 77 112 117 291 75 88 57 43 82 93 121
2024/20252.442 91 201 54 227 240 78 63 268 107 260 230 623
2025/20264.971 542 360 438 423 530 333 756 225 541 445 378 0
Totale 18.919